David W. Gryska - Feb 7, 2022 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Director
Signature
By: /s/ Jennifer Prosba For: David W. Gryska
Stock symbol
SGEN
Transactions as of
Feb 7, 2022
Transactions value $
-$534,171
Form type
4
Date filed
2/9/2022, 05:58 PM
Previous filing
Feb 1, 2022
Next filing
Apr 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $22.1K +1.1K +2.38% $20.06* 47.4K Feb 7, 2022 Direct F1
transaction SGEN Common Stock Sale -$151K -1.1K -2.32% $137.45 46.3K Feb 7, 2022 Direct F1, F2, F3
transaction SGEN Common Stock Options Exercise $20.6K +1.03K +2.22% $20.06* 47.3K Feb 7, 2022 Direct F1
transaction SGEN Common Stock Sale -$143K -1.03K -2.18% $138.66 46.3K Feb 7, 2022 Direct F1, F2, F4
transaction SGEN Common Stock Options Exercise $47.6K +2.37K +5.13% $20.06* 48.6K Feb 7, 2022 Direct F1
transaction SGEN Common Stock Sale -$331K -2.37K -4.88% $139.42 46.3K Feb 7, 2022 Direct F1, F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.1K -12.94% $0.00 7.4K Feb 7, 2022 Common Stock 1.1K $20.06 Direct F6
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.03K -13.91% $0.00 6.37K Feb 7, 2022 Common Stock 1.03K $20.06 Direct F6
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.37K -37.22% $0.00 4K Feb 7, 2022 Common Stock 2.37K $20.06 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $137.03 to $137.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of common stock executed in multiple transactions at prices ranging from $138.03 to $139.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Reflects sales of common stock executed in multiple transactions at prices ranging from $139.20 to $139.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6 Options were fully vested on 5/17/13.